[
    [
        {
            "time": "2019-04-30",
            "original_text": "Health Care Sector Update for 04/30/2019: LLY, PFE, NVS, JNJ, ABTX, MRK, AMGN",
            "features": {
                "keywords": [
                    "LLY",
                    "PFE",
                    "NVS",
                    "JNJ",
                    "ABTX",
                    "MRK",
                    "AMGN"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 10,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "2019-04-30",
            "original_text": "Incyte (INCY) Q1 Earnings & Revenues Beat Estimates, Up Y/Y",
            "features": {
                "keywords": [
                    "INCY",
                    "Q1",
                    "Earnings",
                    "Beat",
                    "Estimates",
                    "Up",
                    "Y/Y"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-04-30",
            "original_text": "Novartisâ€™s Oncology Business Continues Its Strong Showing in Q1",
            "features": {
                "keywords": [
                    "Novartis",
                    "Oncology",
                    "Business",
                    "Strong",
                    "Showing",
                    "Q1"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "oncology",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2019-04-30",
            "original_text": "Is a Beat in the Cards for Incyte (INCY) in Q1 Earnings?",
            "features": {
                "keywords": [
                    "INCY",
                    "Q1",
                    "Earnings",
                    "Beat"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2019-04-30",
            "original_text": "Can 'synthetic lethality' and deep experience propel this cancer-fighting biotech's $70M IPO?",
            "features": {
                "keywords": [
                    "synthetic lethality",
                    "cancer-fighting",
                    "biotech",
                    "IPO"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 5,
                "Duration": 9,
                "Entity_Density": 5,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        },
        {
            "time": "2019-04-30",
            "original_text": "Biotech Stocks for a Long-Lived Portfolio",
            "features": {
                "keywords": [
                    "Biotech",
                    "Stocks",
                    "Long-Lived",
                    "Portfolio"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "biotech"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Biotech Stocks for a Long-Lived Portfolio",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]